Mortenson Mark 4

What Happened
Mark Mortenson, Chief Science Officer of Clene Inc. (CLNN), was granted an option award for 75,000 shares of common stock on January 22, 2026. The Form 4 reports the award as a derivative grant (acquisition price $0.00); per the filing footnote the options carry an exercise price of $5.42 per share and vest immediately upon grant. This is an equity compensation award (not an open-market purchase or sale).

Key Details

• Transaction date: January 22, 2026; Form 4 filed January 23, 2026 (timely filing).
• Transaction type/code: Award/Grant (reported as A). Acquisition reported at $0.00; exercise price is $5.42 per share (footnote).
• Shares/units involved: 75,000 stock options.
• Shares owned after transaction: Not disclosed in this filing.
• Footnote: The options were granted under the Clene Inc. Amended 2020 Stock Plan and vest immediately upon grant.
• No indication of a 10b5-1 plan, tax withholding, cashless exercise, or an immediate sale in this filing.

Context
This filing documents a grant of stock options — the right to buy common shares at $5.42 each — rather than an outright purchase or sale of shares. Immediate vesting means the options can be exercised right away, but exercising would require paying the $5.42 exercise price and would be reported separately if exercised or sold. Equity awards are common for executive compensation; they do not by themselves indicate the insider is buying or selling stock on the open market.